Infectious Disease Models CROs for Rabbit Studies

4 contract research organizations in our directory list both Infectious Disease Models and Rabbit among their capabilities, across 2 countries. 3 report GLP capability and 0 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.

4 CROs 3 GLP 2 countries

Infectious Disease Models CROs for Rabbit Studies

Showing 4 CROs. Order rotates daily so no lab is permanently listed first.

IBT Bioservices (Integrated BioTherapeutics)

US

Maryland CRO specializing in infectious disease and vaccine research, offering in vitro and in vivo efficacy models and immunological assays.

Infectious Disease Models Immunogenicity Testing In Vivo Efficacy Vaccine Development Rabbit Mouse Rat

Bridge PTS

US GLP

Preclinical research company specializing in wound healing, biofilm and infection models for drugs and medical devices, including custom surgical models and electron microscopy.

Infectious Disease Models Electron Microscopy Medical Device Testing Surgical Models Wound Healing Models Rabbit Mouse Pig Rat

MRIGlobal

US GLP

Independent nonprofit contract research organization with capabilities including inhalation toxicology and high-containment infectious disease research.

Infectious Disease Models Inhalation Toxicity Toxicology Rabbit Mouse Rat

Nihon Bioresearch

JP GLP

Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.

Infectious Disease Models GLP Toxicology In Vivo Efficacy Medical Device Testing Safety Pharmacology Rabbit Minipig Mouse Rat

Questions to ask when choosing an Infectious Disease Models in Rabbit CRO

  • Is your facility approved for our organism at the required containment level, ABSL-2 or ABSL-3?
  • Which challenge strains do you hold, and how are inocula prepared and titrated?
  • Do you run antimicrobial PK/PD, including dose fractionation, in the same model?
  • Which immunogenicity assays do you run in-house: binding titers, neutralization, T-cell assays?
  • What humane endpoints do you use in lethal challenge models?